{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T23:46:58Z","timestamp":1768434418321,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.clinbiochem.2021.05.007","type":"journal-article","created":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T11:15:28Z","timestamp":1620990928000},"page":"34-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Association of ovarian response with picoAMH in women undergoing controlled ovarian hyperstimulation"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2311-5615","authenticated-orcid":false,"given":"J.","family":"Bruno-Gaston","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Zarutskie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Gibbons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Devaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2021.05.007_b0005","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ajog.2017.02.027","article-title":"Ovarian reserve testing: a user's guide","volume":"217","author":"Tal","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.clinbiochem.2021.05.007_b0010","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/humrep\/deu266","article-title":"Ovarian response prediction in GnRH antagonist treatment for IVF using anti-Mullerian hormone","volume":"30","author":"Hamdine","year":"2015","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.clinbiochem.2021.05.007_b0015","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1477-7827-10-32","article-title":"Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment","volume":"10","author":"Fiedler","year":"2012","journal-title":"Reproduct. Biol. Endocrinol. RB&E"},{"key":"10.1016\/j.clinbiochem.2021.05.007_b0020","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/humrep\/dem254","article-title":"Serum anti-Mullerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles","volume":"23","author":"Lee","year":"2008","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.clinbiochem.2021.05.007_b0025","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/bs.vh.2018.01.018","article-title":"The ovarian hyperstimulation syndrome","volume":"107","author":"Blumenfeld","year":"2018","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.clinbiochem.2021.05.007_b0030","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/humrep\/deg042","article-title":"Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3","volume":"18","author":"Fanchin","year":"2003","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.clinbiochem.2021.05.007_b0035","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1093\/humrep\/del291","article-title":"Serum anti-Mullerian hormone throughout the human menstrual cycle","volume":"21","author":"La Marca","year":"2006","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.clinbiochem.2021.05.007_b0040","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/humrep\/deu142","article-title":"Biological variability in serum anti-Mullerian hormone throughout the menstrual cycle in ovulatory and sporadic anovulatory cycles in eumenorrheic women","volume":"29","author":"Kissell","year":"2014","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.clinbiochem.2021.05.007_b0045","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1210\/jc.2006-0331","article-title":"Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation","volume":"91","author":"Hehenkamp","year":"2006","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.clinbiochem.2021.05.007_b0050","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/j.1600-0412.2012.01471.x","article-title":"The role of anti-mullerian hormone in female fertility and infertility \u2013 An overview","volume":"91","author":"Grynnerup","year":"2012","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.clinbiochem.2021.05.007_b0055","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1477-7827-5-9","article-title":"Ovarian volume and antral follicle count for the prediction of low and hyper responders with in vitro fertilization","volume":"5","author":"Kwee","year":"2007","journal-title":"Reproduct. Biol. Endocrinol. RB&E"},{"key":"10.1016\/j.clinbiochem.2021.05.007_b0060","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.fertnstert.2007.12.013","article-title":"The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count","volume":"91","author":"Broer","year":"2009","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.clinbiochem.2021.05.007_b0065","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/humupd\/dmu062","article-title":"Technical and performance characteristics of anti-Mullerian hormone and antral follicle count as biomarkers of ovarian response","volume":"21","author":"Iliodromiti","year":"2015","journal-title":"Hum. Reproduct. Update"},{"key":"10.1016\/j.clinbiochem.2021.05.007_b0070","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/humrep\/deh688","article-title":"High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status","volume":"20","author":"Fanchin","year":"2005","journal-title":"Hum. Reprod."},{"issue":"1012\u20131018","key":"10.1016\/j.clinbiochem.2021.05.007_b0075","article-title":"Value of antimullerian hormone as a prognostic indicator of in vitro fertilization outcome","volume":"101","author":"Reichman","year":"2014","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.clinbiochem.2021.05.007_b0080","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.maturitas.2017.04.004","article-title":"A quantitative comparison of anti-Mullerian hormone measurement and its shifting boundaries between two assays","volume":"101","author":"de Kat","year":"2017","journal-title":"Maturitas"},{"key":"10.1016\/j.clinbiochem.2021.05.007_b0085","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12958-020-00641-9","article-title":"Establishment of a WHO reference reagent for anti-mullerian hormone","volume":"18","author":"Ferguson","year":"2020","journal-title":"Reproduct. Biol. Endocrinol. RB&E"},{"key":"10.1016\/j.clinbiochem.2021.05.007_b0090","doi-asserted-by":"crossref","unstructured":"Magnusson, A., Olerod, G., Thurin-Kjellberg, A., and Bergh, C. (2017) The correlation between AMH assays differs depending on actual AMH levels, Human reproduction open 2017, hox026.","DOI":"10.1093\/hropen\/hox026"},{"key":"10.1016\/j.clinbiochem.2021.05.007_b0095","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa513","article-title":"Anti-mullerian hormone and ovarian reserve: update on assessing ovarian function","volume":"105","author":"Moolhuijsen","year":"2020","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.clinbiochem.2021.05.007_b0100","article-title":"Validation of the picoAMH assay on the Dynex DS2 platform","volume":"17","author":"Garnett","year":"2019","journal-title":"Pract. Laborat. Med."},{"key":"10.1016\/j.clinbiochem.2021.05.007_b0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12958-019-0452-4","article-title":"Prediction of the lower serum anti-Mullerian hormone threshold for ovarian stimulation prior to in-vitro fertilization using the Elecsys(R) AMH assay: a prospective observational study","volume":"17","author":"Grynnerup","year":"2019","journal-title":"Reproduct. Biol. Endocrinol. RB&E"},{"key":"10.1016\/j.clinbiochem.2021.05.007_b0110","unstructured":"Visser, J. A., Laven J.S., Kumar A. Development of a sensitive and human specifie AMH chemiluminescence assay for the quantitative measurment of AMH in serum, plasam and follicular fluid."},{"key":"10.1016\/j.clinbiochem.2021.05.007_b0115","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2265.2005.02336.x","article-title":"Development of a sensitive enzyme immunoassay for anti-Mullerian hormone and the evaluation of potential clinical applications in males and females","volume":"63","author":"Al-Qahtani","year":"2005","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.clinbiochem.2021.05.007_b0120","article-title":"Role of baseline antral follicle count and anti-Mullerian hormone in prediction of cumulative live birth in the first in vitro fertilisation cycle: a retrospective cohort analysis","volume":"8","author":"Li","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.clinbiochem.2021.05.007_b0125","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1093\/humrep\/dey098","article-title":"Discordance between serum anti-Mullerian hormone concentrations and antral follicle counts: not only technical issues","volume":"33","author":"Alebic","year":"2018","journal-title":"Hum. Reprod."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991202100148X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991202100148X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:10:08Z","timestamp":1762114208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000991202100148X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":25,"alternative-id":["S000991202100148X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2021.05.007","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of ovarian response with picoAMH in women undergoing controlled ovarian hyperstimulation","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2021.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc. on behalf of The Canadian Society of Clinical Chemists.","name":"copyright","label":"Copyright"}]}}